Summary
- Current Price
- As of today, SPRO price is $1.13, unchanged in the most recent trading session on
- Current Price All-Time High
- SPRO price is currently -95.22% below its historical high of $23.64 set on
- Market Cap
- SPRO current market cap is $66M, down -41.44% year-over-year
- PE Ratio
- SPRO current PE ratio is 10.36
- Revenue
- SPRO current annual revenue is $59.62M, up +117.62% year-over-year
- Next Earnings
- The next earnings release for SPRO is on
Profile
| Metric | Value |
|---|---|
| Full Name | Spero Therapeutics, Inc. |
| Ticker | NASDAQ: SPRO |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | sperotherapeutics.com |
| Employees | 32 |
Key Metrics
| Metric | Value | Date |
|---|---|---|
| $1.13 | ||
| Price, 1D Change | 0.00% | |
| $66M | ||
| - | ||
| 10.36 | ||
| 1.49 | ||
| $59.62M | ||
| Revenue, 1Y Change | +117.62% | |
| $0.15 | ||
| EPS, 1Y Change | +111.44% |
Chart
SUGGESTED SERIES
Events
| Metric | Value | Date |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Value | Date |
|---|---|---|
| $0.15 | ||
| EPS Estimate | -$0.58 | N/A |
| EPS Est. Change | -499.45% | N/A |
| $59.62M | ||
| Revenue Estimate | $258.00K | N/A |
| Revenue Est. Change | -99.57% | N/A |
| $1.13 | ||
| Price Target | $5.00 | - |
| Price Tgt. Change | +342.48% | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | -$1.27 | - | |
| - | $0.15 | - | |
| -$0.58 | N/A | -499.45% | |
| -$0.11 | N/A | -172.31% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $27.40M | - | |
| - | $59.62M | - | |
| $258.00K | N/A | -99.57% | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Value | Date |
|---|---|---|
| -43.50% | ||
| -7.38% | ||
| -41.44% | ||
| +2.60% | ||
| +117.62% | ||
| +22.73% | ||
| +111.44% | ||
| +111.76% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Value | Date |
|---|---|---|
| $1.13 | ||
| $2.16 | ||
| $1.28 | ||
| $1.93 | ||
| $1.38 | ||
| -$0.06 | ||
| 1.49 | ||
| $0.05 | ||
| 34.45 | ||
| 26.92% |
Dividends
| Metric | Value | Date |
|---|---|---|
| - | N/A | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Value | Date |
|---|---|---|
| $59.62M | ||
| $0.15 | ||
| $0.00 | ||
| 0.00% | ||
| -$24.00K | ||
| -0.04% | ||
| $8.57M | ||
| 14.38% | ||
| -$24.00K |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Value | Date |
|---|---|---|
| 0.05 | ||
| 7.59 | ||
| 7.59 | ||
| - | ||
| - | ||
| -3.29 |
Valuations
| Metric | Value | Date |
|---|---|---|
| 10.36 | ||
| 1.53 | ||
| 1.49 | ||
| 6.62 | ||
| - | N/A |
Balance Sheet
| Metric | Value | Date |
|---|---|---|
| $59.02M | ||
| $40.27M | ||
| $68.92M | ||
| $67.29M | ||
| $9.90M | ||
| $8.87M | ||
| $2.90M | ||
| $1.96M | ||
| $693.00K |
Expenses
| Metric | Value | Date |
|---|---|---|
| $51.05M | ||
| $24.00K | ||
| - | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| $261.00K |
Cash Flow
| Metric | Value | Date |
|---|---|---|
| -$12.62M | ||
| $0.00 | ||
| $0.00 | ||
| $0.00 | ||
| -$12.62M |
Recent analyst updates
| Metric | Value | Date |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Evercore ISI Group | → | |
| HC Wainwright & Co. | → | |
| TD Cowen | → | |
| Cantor Fitzgerald | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| TD Cowen | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with SPRO
FAQ
- What is the ticker symbol for Spero Therapeutics, Inc.?
- The ticker symbol for Spero Therapeutics, Inc. is NASDAQ:SPRO
- Does Spero Therapeutics, Inc. pay dividends?
- No, Spero Therapeutics, Inc. does not pay dividends
- What sector is Spero Therapeutics, Inc. in?
- Spero Therapeutics, Inc. is in the Healthcare sector
- What industry is Spero Therapeutics, Inc. in?
- Spero Therapeutics, Inc. is in the Biotechnology industry
- What country is Spero Therapeutics, Inc. based in?
- Spero Therapeutics, Inc. is headquartered in United States
- When did Spero Therapeutics, Inc. go public?
- Spero Therapeutics, Inc. initial public offering (IPO) was on November 2, 2017
- Is Spero Therapeutics, Inc. in the S&P 500?
- No, Spero Therapeutics, Inc. is not included in the S&P 500 index
- Is Spero Therapeutics, Inc. in the NASDAQ 100?
- No, Spero Therapeutics, Inc. is not included in the NASDAQ 100 index
- Is Spero Therapeutics, Inc. in the Dow Jones?
- No, Spero Therapeutics, Inc. is not included in the Dow Jones index
- When was Spero Therapeutics, Inc. last earnings report?
- Spero Therapeutics, Inc.'s most recent earnings report was on August 12, 2026
- When does Spero Therapeutics, Inc. report earnings?
- The next expected earnings date for Spero Therapeutics, Inc. is November 12, 2026
Data Sources & References
- SPRO Official Website sperotherapeutics.com
- SPRO Profile on Yahoo Finance finance.yahoo.com/quote/SPRO
- SPRO Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/spro